Actively Recruiting
A Multicenter Study to Assess the Safety and Effectiveness of Coroflex ISAR NEO Stents in Patients with Coronary Artery Disease in Routine Care
Led by Seung-Jung Park · Updated on 2026-06-25
1000
Participants Needed
11
Research Sites
208 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the effectiveness and safety of Coroflex ISAR NEO stents compared to other drug-eluting stents in real-world medical practice. The study focuses on patients with coronary artery stenosis and coronary artery disease who undergo percutaneous coronary intervention. It is a multicenter, prospective observational study that tracks outcomes over an extended period. Participants receive the Coroflex ISAR NEO stent as part of their routine care during percutaneous coronary intervention. The study monitors these patients without altering their treatment, gathering data on outcomes such as death, nonfatal heart attacks, and the need for additional procedures on the treated vessels. The study collects information up to 5 years after the procedure to assess long-term safety and effectiveness. During the study, participants will undergo regular clinical follow-up visits as per the study schedule and provide informed consent. Researchers will measure outcomes including the combined rates of death, heart attack, and vessel revascularization at 12 months, along with various other cardiovascular events over 5 years. Procedural success will also be evaluated in the initial days following treatment. The total participation can last up to several years to capture comprehensive safety and effectiveness data.
CONDITIONS
Brief Title
IRIS-Coroflex NEO Cohort
Research Team
J
Jung-Hee Ham, Project manager
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here